KIR3DL1 and Cirrhosis: Furthermore, KIR3DL1 expression was also decreased in peripheral blood CD56dim NK cells (together with its Bw4 ligand) from the group of early-infected patients who developed cirrhosis (5 vs. 32% in patients without cirrhosis, p = 0.03; Figure 4C).